| 2429 |
Instability/dysfunction of INSIG1
Short Name
Instability of INSIG1
|
0 |
Molecular |
Jun 9, 2026 |
Jun 9, 2026 |
None
|
| 2386 |
Lipid-peroxidation overload
Short Name
Lipid-peroxidation overload
|
0 |
Cellular |
Nov 4, 2025 |
Nov 4, 2025 |
None
|
| 2411 |
Increase, Circulating active glucocorticoid availability
Short Name
Increase, Circulating active GC availability
|
0 |
Organ |
Feb 18, 2026 |
Feb 24, 2026 |
None
|
| 2392 |
Depression
Short Name
Depression
|
0 |
Individual |
Nov 9, 2025 |
Nov 10, 2025 |
None
|
| 2368 |
immature oocyte
Short Name
immature oocyte
|
0 |
Cellular |
Sep 9, 2025 |
Sep 9, 2025 |
None
|
| 2372 |
Squamous metaplasia, Increase
Short Name
Squamous metaplasia, Increase
|
1 |
Cellular |
Sep 12, 2025 |
Sep 16, 2025 |
None
|
| 2259 |
Altered, Microbial Bile Acid Metabolism
Short Name
Microbial Bile Acid Dysmetabolism
|
0 |
Molecular |
Aug 29, 2024 |
Aug 29, 2024 |
None
|
| 2235 |
Increased incidence and mortality of liver diseases among children
Short Name
Increased incidence and mortality of liver diseases among children
|
0 |
Population |
Jun 26, 2024 |
Jun 26, 2024 |
None
|
| 2234 |
Malignant transformation of cells
Short Name
Malignant transformation of cells
|
0 |
Cellular |
Jun 26, 2024 |
Jun 26, 2024 |
None
|
| 2246 |
Increased sympathetic nerve activity
Short Name
Increased sympathetic nerve activity
|
0 |
Cellular |
Jul 29, 2024 |
Jul 29, 2024 |
None
|
| 2247 |
Increased incidence of cerebrovascular morbidility and mortality in the general population
Short Name
Increased incidence of cerebrovascular disease
|
0 |
Population |
Jul 29, 2024 |
Jul 29, 2024 |
None
|
| 2248 |
Increased stress hormone
Short Name
Increased stress hormone
|
0 |
Cellular |
Jul 29, 2024 |
Jul 29, 2024 |
None
|
| 2249 |
Activation of sensory receptors
Short Name
Activation of sensory receptors
|
0 |
Molecular |
Jul 29, 2024 |
Jul 29, 2024 |
None
|
| 2325 |
Decreased number of LT CD8+ cells
Short Name
Decreased number of LT CD8+ cells
|
0 |
Cellular |
May 16, 2025 |
Jun 11, 2025 |
None
|
| 2360 |
Activation of steroidogenesis
Short Name
steroidogenesis
|
0 |
Cellular |
Sep 2, 2025 |
Sep 2, 2025 |
None
|
| 2359 |
HPG axis
Short Name
HPG axis
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2358 |
endocrine disruption
Short Name
endocrine disruption
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2357 |
ovary
Short Name
ovary retardation
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2356 |
vitellogenin
Short Name
vtg
|
0 |
Molecular |
Aug 29, 2025 |
Aug 29, 2025 |
None
|
| 2361 |
Hypothalamus–Pituitary–Gonad) axis disruption
Short Name
HPG axis disruption
|
0 |
Organ |
Sep 2, 2025 |
Sep 2, 2025 |
None
|
| 2313 |
Increased, Cardiovascular fibrosis
Short Name
Increased, Cardiovascular fibrosis
|
0 |
Organ |
Mar 11, 2025 |
Mar 11, 2025 |
None
|
| 2314 |
Increased, Cardiovascular dysfunction
Short Name
Cardiovascular dysfunction
|
0 |
Individual |
Mar 11, 2025 |
Mar 11, 2025 |
None
|
| 2315 |
Increased, Incidence of cardiovascular disease
Short Name
Increased, Incidence of cardiovascular disease
|
0 |
Population |
Mar 11, 2025 |
Mar 11, 2025 |
None
|
| 2318 |
Decreased 3-beta-HSD activity
Short Name
Decreased 3βHSD activity
|
0 |
Tissue |
Apr 8, 2025 |
Apr 8, 2025 |
None
|
| 2319 |
Decreased, Pregnenolone levels
Short Name
Decreased, Pregnenolone levels
|
0 |
Tissue |
Apr 8, 2025 |
Apr 8, 2025 |
None
|